Cargando…
Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients
COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms m...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783208/ https://www.ncbi.nlm.nih.gov/pubmed/35221076 http://dx.doi.org/10.1016/j.ccep.2021.10.001 |
_version_ | 1784638481376477184 |
---|---|
author | Magnocavallo, Michele Vetta, Giampaolo Della Rocca, Domenico G. Gianni, Carola Mohanty, Sanghamitra Bassiouny, Mohamed Di Lullo, Luca Del Prete, Armando Cirone, Donatello Lavalle, Carlo Chimenti, Cristina Al-Ahmad, Amin Burkhardt, J. David Gallinghouse, G. Joseph Sanchez, Javier E. Horton, Rodney P. Di Biase, Luigi Natale, Andrea |
author_facet | Magnocavallo, Michele Vetta, Giampaolo Della Rocca, Domenico G. Gianni, Carola Mohanty, Sanghamitra Bassiouny, Mohamed Di Lullo, Luca Del Prete, Armando Cirone, Donatello Lavalle, Carlo Chimenti, Cristina Al-Ahmad, Amin Burkhardt, J. David Gallinghouse, G. Joseph Sanchez, Javier E. Horton, Rodney P. Di Biase, Luigi Natale, Andrea |
author_sort | Magnocavallo, Michele |
collection | PubMed |
description | COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management. |
format | Online Article Text |
id | pubmed-8783208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87832082022-01-24 Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients Magnocavallo, Michele Vetta, Giampaolo Della Rocca, Domenico G. Gianni, Carola Mohanty, Sanghamitra Bassiouny, Mohamed Di Lullo, Luca Del Prete, Armando Cirone, Donatello Lavalle, Carlo Chimenti, Cristina Al-Ahmad, Amin Burkhardt, J. David Gallinghouse, G. Joseph Sanchez, Javier E. Horton, Rodney P. Di Biase, Luigi Natale, Andrea Card Electrophysiol Clin Article COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management. Elsevier Inc. 2022-03 2022-01-22 /pmc/articles/PMC8783208/ /pubmed/35221076 http://dx.doi.org/10.1016/j.ccep.2021.10.001 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Magnocavallo, Michele Vetta, Giampaolo Della Rocca, Domenico G. Gianni, Carola Mohanty, Sanghamitra Bassiouny, Mohamed Di Lullo, Luca Del Prete, Armando Cirone, Donatello Lavalle, Carlo Chimenti, Cristina Al-Ahmad, Amin Burkhardt, J. David Gallinghouse, G. Joseph Sanchez, Javier E. Horton, Rodney P. Di Biase, Luigi Natale, Andrea Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title | Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title_full | Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title_fullStr | Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title_full_unstemmed | Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title_short | Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients |
title_sort | prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783208/ https://www.ncbi.nlm.nih.gov/pubmed/35221076 http://dx.doi.org/10.1016/j.ccep.2021.10.001 |
work_keys_str_mv | AT magnocavallomichele prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT vettagiampaolo prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT dellaroccadomenicog prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT giannicarola prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT mohantysanghamitra prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT bassiounymohamed prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT dilulloluca prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT delpretearmando prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT cironedonatello prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT lavallecarlo prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT chimenticristina prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT alahmadamin prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT burkhardtjdavid prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT gallinghousegjoseph prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT sanchezjaviere prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT hortonrodneyp prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT dibiaseluigi prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients AT nataleandrea prevalencemanagementandoutcomeofatrialfibrillationandothersupraventriculararrhythmiasincovid19patients |